Hyaluronan Inhibition as a Therapeutic Target for Diabetic Kidney Disease: What Is Next?
{{output}}
Diabetic kidney disease (DKD) is the leading cause of CKD and ESKD in the United States and worldwide. Pharmacotherapy and lifestyle modifications for glycemia, dyslipidemia, and BP control have shown success in slowing the progression of DKD. Traditional trea... ...
